Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-02-25 17:44:31 -

BB Biotech AG /
Director's Dealings announcement according to §15a WpHG (the German Securities 
Trading Act) 
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. 

--------------------------------------------------------------------------------
Details of the person subject to the disclosure requirement
--------------------------------------------------------------------------------
Name:                   Koller,  Daniel

Professional role:      Person with executive functions:   Member of a managing
                        body


--------------------------------------------------------------------------------
Designation of the financial instrument
--------------------------------------------------------------------------------
ISIN: 
CH0038389992 Designation: Registered share BB Biotech AG -------------------------------------------------------------------------------- Details of the transaction -------------------------------------------------------------------------------- Type of transaction: Buy Date: 21.02.2013 Place (stock exchange): SIX Swiss Exchange Price: 96.85 Currency: CHF Quantity: 200 Business volume: 19370 -------------------------------------------------------------------------------- Details of the company with the publishing obligation: -------------------------------------------------------------------------------- Issuer: BB Biotech AG Vordergasse 3 CH-8200   Schaffhausen Switzerland ISIN: CH0038389992 WKN: 888509 This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: BB Biotech AG via Thomson Reuters ONE [HUG#1680881]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser